A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 38
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : rCDI
Long Form : recurrent CDI
No. Year Title Co-occurring Abbreviation
2020 Bezlotoxumab for Preventing Recurrent Clostridioides difficile Infection: A Narrative Review from Pathophysiology to Clinical Studies. CDI, RCTs
2020 Clinical management of severe, fulminant, and refractory Clostridioides difficile infection. CDI, FCDI, FMT, SCDI
2020 Economic evaluation of Faecal microbiota transplantation compared to antibiotics for the treatment of recurrent Clostridioides difficile infection. CDI, FMT, ICER, NGT, NHS, QALY, WTP
2020 Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence. CDI
2020 Excess length of hospital stay, mortality and cost attributable to Clostridioides (Clostridium) difficile infection and recurrence: a nationwide analysis in Japan. LOS
2020 Healthcare resource utilization and direct medical costs associated with index and recurrent Clostridioides difficile infection: a real-world data analysis. CDI, HRU
2020 Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With Cirrhosis. CDI, CI, HR
2020 Pet Ownership Protects Against Recurrence of Clostridioides difficile Infection. CDI, CI, OR
2020 Precision medicine and gut dysbiosis. CDI, FMT
10  2020 Real-world Experience of Bezlotoxumab for Prevention of Clostridioides difficile Infection: A Retrospective Multicenter Cohort Study. CDI, SOC
11  2019 A network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent Clostridium difficile infection. CDI, DFMT, FMT, NWM
12  2019 Bezlotoxumab for the prevention of Clostridium difficile infection: a review of current evidence and safety profile. CDI
13  2019 Current and future trends in clostridioides (clostridium) difficile infection management. CDI, FMT, NTCD
14  2019 Doctor, my patient has CDI and should continue to receive antibiotics. The (unresolved) risk of recurrent CDI. CDI
15  2019 Early Readmission Predicts Increased Mortality in Cirrhosis Patients After Clostridium difficile Infection. CDI, CI, OR
16  2019 Fecal microbiota transplantation as an effective initial therapy for pancreatitis complicated with severe Clostridium difficile infection: A case report. FMT, MSAP, sCDI
17  2019 Influence of Diagnostic Method on Outcomes in Phase 3 Clinical Trials of Bezlotoxumab for the Prevention of Recurrent Clostridioides difficile Infection: A Post Hoc Analysis of MODIFY I/II. CCA, CDI, EIA, ICC, tgPCR
18  2019 Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population. BSA, CDI, CI, HM, HSCT, OR, OVP, VRE
19  2019 Recurrent Clostridium difficile infection is associated with treatment failure and prolonged illness in cancer patients. CDI, MRCDI, SRCDI
20  2019 The perils of PCR-based diagnosis of Clostridioides difficile infections: Painful lessons from clinical trials. CDI, PCR
21  2018 Attributable Healthcare Resource Utilization and Costs for Patients With Primary and Recurrent Clostridium difficile Infection in the United States. CDI, CIs, HCRU
22  2018 BaiCD gene cluster abundance is negatively correlated with Clostridium difficile infection. bai, CDI, FMT, NTCD, TCD
23  2018 Lack of improvement in antimicrobial prescribing after a diagnosis of Clostridium difficile and impact on recurrence. CDI, CI, iCDI, OR
24  2018 Recent Progress for the Effective Prevention and Treatment of Recurrent Clostridium difficile Infection. CDI
25  2018 Tackling the recurrence of Clostridium difficile infection. CDI
26  2017 Bezlotoxumab: anti-toxin B monoclonal antibody to prevent recurrence of Clostridium difficile infection. CDI, SOC
27  2017 Bezlotoxumab: Could This be the Answer for Clostridium difficile Recurrence? BEZ, CDI, SOC
28  2017 Recurrent Clostridium difficile Infection in Children: Patient Risk Factors and Markers of Intestinal Inflammation. CDI, IL
29  2017 Risk factors and impact of Clostridium difficile recurrence on haematology patients. CDI
30  2017 Risk factors for Clostridium difficile infections - an overview of the evidence base and challenges in data synthesis. CDI
31  2016 Recurrent Clostridium difficile infection associates with distinct bile acid and microbiome profiles. BSH, CDI, fCDI
32  2015 Cost-effectiveness analysis of fecal microbiota transplantation for recurrent Clostridium difficile infection. ACG, AGA, CDI, FMT, QALYs
33  2015 Low vitamin D level and impact on severity and recurrence of Clostridium difficile infections. CDI
34  2015 Risk factors for recurrent Clostridium difficile infection: a systematic review and meta-analysis. CDI, CI, PPIs, RR, RRs
35  2014 Cost-effectiveness analysis of treatment strategies for initial Clostridium difficile infection. CDI, FMT, ICER, QALYs
36  2014 Risk factors for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients. CDI, HSCT, nrCDI
37  2014 Treatment of recurrent Clostridium difficile infection: a systematic review. CDI
38  2012 Management and prevention of recurrent clostridium difficile infection in patients after total joint arthroplasty: a review. CDI